Cytel is widely recognized as the industry pioneer of adaptive clinical trials technology and a thought-leader in biostatistical science.
Cytel’s software and advanced analytics are used by over 400 life sciences customers, including 37 of the 40 largest pharmaceutical companies, as well as regulatory bodies such as the FDA.
Through a combination of clinical trial design and optimization software solutions, expert consulting services, tech-enabled real world data analysis platform and specialized resources, Cytel helps its customers to design efficient clinical trials, provide decision-making tools & services and reduce uncertainties across the drug development process, to increase R&D productivity.
Cytel was founded in 1987 by Cyrus Mehta and Nitin Patel, both highly distinguished statisticians and Fellows of the American Statistical Association. Today the company employs more than 1,500 people across 7 countries including many internationally recognized biostaticians.
Cytel is headquartered in Boston, Massachusetts and employs 1,500 people across 7 countries
Global Sales
Cytel's products are used by over 400 life sciences customers, including 37 of the 40 largest pharmaceutical companies, as well as regulatory bodies such as the FDA.
